Physician profile
Eric Todd Falls
NPI 1023180882
$621.86
in general payments reported to CMS, 2019-2025
12 companies · $24.06 in 2025
The $24.06 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.98 · 2021: $48.74 · 2022: $87.75 · 2023: $368 · 2024: $76.45 · 2025: $24.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $280 · Food and Beverage: $188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $280.33 |
| Food and Beverage | $188.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $320.79 | 2023 | Prophecy |
| Amgen INC. | $58.17 | 2024 | Krystexxa |
| Organogenesis INC. | $46.75 | 2021-2023 | Puraply |
| Paratek Pharmaceuticals, INC. | $33.44 | 2022 | |
| Abbott Laboratories | $24.99 | 2021 | |
| Bioventus LLC | $24.09 | 2023 | Exogen Ultrasound Bone Healing System |
| Averitas Pharma INC. | $24.06 | 2025 | Qutenza |
| Depuy Synthes Sales INC. | $20.12 | 2022 | |
| Boston Scientific Corporation | $18.28 | 2024 | |
| Orthofix Medical, INC. | $17.83 | 2022 | |
| Fidia Pharma USA INC. | $16.98 | 2019 | |
| Medtronic, INC. | $16.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Falls listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.